These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11711757)

  • 1. Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality.
    Vutuc C; Waldhoer T; Madersbacher S; Micksche M; Haidinger G
    Eur J Cancer Prev; 2001 Oct; 10(5):425-8. PubMed ID: 11711757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
    Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S
    Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.
    Lai SM; Keighley J; Garimella S; Enko M; Parker WP
    JAMA Netw Open; 2022 Nov; 5(11):e2240657. PubMed ID: 36342715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer screening in the Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur J Cancer; 2000 Jun; 36(10):1322-35. PubMed ID: 10882875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria.
    Bartsch G; Horninger W; Klocker H; Reissigl A; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P;
    Urology; 2001 Sep; 58(3):417-24. PubMed ID: 11549491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA testing in Austria: induced morbidity and saved mortality.
    Vutuc C; Waldhoer T; Lunglmayr G; Hoeltl W; Haidinger G
    Eur J Cancer Prev; 2009 Sep; 18(5):377-80. PubMed ID: 19512934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer and prostate-specific antigen testing in New South Wales.
    Smith DP; Supramaniam R; Marshall VR; Armstrong BK
    Med J Aust; 2008 Sep; 189(6):315-8. PubMed ID: 18803534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study.
    Møller MH; Kristiansen IS; Beisland C; Rørvik J; Støvring H
    BJU Int; 2016 Oct; 118(4):547-55. PubMed ID: 26497872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.
    Hoffman RM; Meisner AL; Arap W; Barry M; Shah SK; Zeliadt SB; Wiggins CL
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):259-63. PubMed ID: 26646364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.
    Negoita S; Feuer EJ; Mariotto A; Cronin KA; Petkov VI; Hussey SK; Benard V; Henley SJ; Anderson RN; Fedewa S; Sherman RL; Kohler BA; Dearmon BJ; Lake AJ; Ma J; Richardson LC; Jemal A; Penberthy L
    Cancer; 2018 Jul; 124(13):2801-2814. PubMed ID: 29786851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
    Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
    Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia.
    Luo Q; Yu XQ; Kahn C; Egger S; Patel MI; Grogan PB; Caruana M; Canfell K; Smith DP; O'Connell DL
    Cancer Epidemiol; 2022 Jun; 78():102159. PubMed ID: 35447540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International trends in prostate-cancer mortality in the "PSA ERA".
    Oliver SE; May MT; Gunnell D
    Int J Cancer; 2001 Jun; 92(6):893-8. PubMed ID: 11351313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
    Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
    Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
    Kelly SP; Anderson WF; Rosenberg PS; Cook MB
    Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?
    Feletto E; Bang A; Cole-Clark D; Chalasani V; Rasiah K; Smith DP
    World J Urol; 2015 Nov; 33(11):1677-87. PubMed ID: 25698456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population.
    Orsted DD; Nordestgaard BG; Jensen GB; Schnohr P; Bojesen SE
    Eur Urol; 2012 May; 61(5):865-74. PubMed ID: 22104593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.
    Li J; Siegel DA; King JB
    Ann Epidemiol; 2018 May; 28(5):328-330. PubMed ID: 29678312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.